Scott Biller
Director/Miembro de la Junta en FOGHORN THERAPEUTICS INC. .
Fortuna: - $ al 31/05/2024
Cargos activos de Scott Biller
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FOGHORN THERAPEUTICS INC. | Director/Miembro de la Junta | 09/01/2020 | - |
| Independent Dir/Board Member | 09/01/2020 | - | |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | 01/06/2020 | - |
Rome Therapeutics, Inc.
 Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | 01/02/2021 | - |
Historial de carrera de Scott Biller
Antiguos cargos conocidos de Scott Biller.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/09/2010 | 31/12/2019 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2003 | 01/09/2010 |
| Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | 01/06/2001 | 01/07/2003 |
Formación de Scott Biller.
| Massachusetts Institute of Technology | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
Operativa
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorial
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Bristol-Myers Squibb Pharmaceutical Research Institute | |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
Rome Therapeutics, Inc.
Rome Therapeutics, Inc. BiotechnologyHealth Technology Rome Therapeutics, Inc. develops novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome-vast stretches of uncharted genetic materials. The company was founded by Rosana Kapeller and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Scott Biller
- Experiencia
